215 related articles for article (PubMed ID: 22287548)
21. Tumor-associated macrophages promote angiogenesis and melanoma growth via adrenomedullin in a paracrine and autocrine manner.
Chen P; Huang Y; Bong R; Ding Y; Song N; Wang X; Song X; Luo Y
Clin Cancer Res; 2011 Dec; 17(23):7230-9. PubMed ID: 21994414
[TBL] [Abstract][Full Text] [Related]
22. Mammalian target of rapamycin pathway promotes tumor-induced angiogenesis in adenoid cystic carcinoma: its suppression by isoliquiritigenin through dual activation of c-Jun NH2-terminal kinase and inhibition of extracellular signal-regulated kinase.
Sun ZJ; Chen G; Zhang W; Hu X; Huang CF; Wang YF; Jia J; Zhao YF
J Pharmacol Exp Ther; 2010 Aug; 334(2):500-12. PubMed ID: 20484154
[TBL] [Abstract][Full Text] [Related]
23. Identification of S664 TSC2 phosphorylation as a marker for extracellular signal-regulated kinase mediated mTOR activation in tuberous sclerosis and human cancer.
Ma L; Teruya-Feldstein J; Bonner P; Bernardi R; Franz DN; Witte D; Cordon-Cardo C; Pandolfi PP
Cancer Res; 2007 Aug; 67(15):7106-12. PubMed ID: 17671177
[TBL] [Abstract][Full Text] [Related]
24. Activation of mTOR by human T-cell leukemia virus type 1 Tax is important for the transformation of mouse T cells to interleukin-2-independent growth.
Yoshita M; Higuchi M; Takahashi M; Oie M; Tanaka Y; Fujii M
Cancer Sci; 2012 Feb; 103(2):369-74. PubMed ID: 22010857
[TBL] [Abstract][Full Text] [Related]
25. Tuberin and PRAS40 are anti-apoptotic gatekeepers during early human amniotic fluid stem-cell differentiation.
Fuchs C; Rosner M; Dolznig H; Mikula M; Kramer N; Hengstschläger M
Hum Mol Genet; 2012 Mar; 21(5):1049-61. PubMed ID: 22090422
[TBL] [Abstract][Full Text] [Related]
26. All roads lead to mTOR: integrating inflammation and tumor angiogenesis.
Lee DF; Hung MC
Cell Cycle; 2007 Dec; 6(24):3011-4. PubMed ID: 18073529
[TBL] [Abstract][Full Text] [Related]
27. Antitumor and antimetastatic actions of xanthoangelol and 4-hydroxyderricin isolated from Angelica keiskei roots through the inhibited activation and differentiation of M2 macrophages.
Sumiyoshi M; Taniguchi M; Baba K; Kimura Y
Phytomedicine; 2015 Jul; 22(7-8):759-67. PubMed ID: 26141763
[TBL] [Abstract][Full Text] [Related]
28. Inhibition of mTOR blocks the anti-inflammatory effects of glucocorticoids in myeloid immune cells.
Weichhart T; Haidinger M; Katholnig K; Kopecky C; Poglitsch M; Lassnig C; Rosner M; Zlabinger GJ; Hengstschläger M; Müller M; Hörl WH; Säemann MD
Blood; 2011 Apr; 117(16):4273-83. PubMed ID: 21368289
[TBL] [Abstract][Full Text] [Related]
29. Tumor-associated vacuolar ATPase subunit promotes tumorigenic characteristics in macrophages.
Katara GK; Jaiswal MK; Kulshrestha A; Kolli B; Gilman-Sachs A; Beaman KD
Oncogene; 2014 Dec; 33(49):5649-54. PubMed ID: 24362525
[TBL] [Abstract][Full Text] [Related]
30. TSC1 controls macrophage polarization to prevent inflammatory disease.
Zhu L; Yang T; Li L; Sun L; Hou Y; Hu X; Zhang L; Tian H; Zhao Q; Peng J; Zhang H; Wang R; Yang Z; Zhang L; Zhao Y
Nat Commun; 2014 Sep; 5():4696. PubMed ID: 25175012
[TBL] [Abstract][Full Text] [Related]
31. Inflammatory Characteristics of Monocytes from Pediatric Patients with Tuberous Sclerosis.
Meyer CU; Kurlemann G; Sauter M; Wiemer-Kruel A; Hahn A; Doganci A; Birkholz J; Faber J; Gehring S; Hertzberg C; Zepp F; Knuf M
Neuropediatrics; 2015 Oct; 46(5):335-43. PubMed ID: 26356487
[TBL] [Abstract][Full Text] [Related]
32. Brain-expressed X-linked 2 Is Pivotal for Hyperactive Mechanistic Target of Rapamycin (mTOR)-mediated Tumorigenesis.
Hu Z; Wang Y; Huang F; Chen R; Li C; Wang F; Goto J; Kwiatkowski DJ; Wdzieczak-Bakala J; Tu P; Liu J; Zha X; Zhang H
J Biol Chem; 2015 Oct; 290(42):25756-65. PubMed ID: 26296882
[TBL] [Abstract][Full Text] [Related]
33. A role of the mammalian target of rapamycin (mTOR) in glutamate-induced down-regulation of tuberous sclerosis complex proteins 2 (TSC2).
Ru W; Peng Y; Zhong L; Tang SJ
J Mol Neurosci; 2012 Jun; 47(2):340-5. PubMed ID: 22492229
[TBL] [Abstract][Full Text] [Related]
34. Rapamycin unbalances the polarization of human macrophages to M1.
Mercalli A; Calavita I; Dugnani E; Citro A; Cantarelli E; Nano R; Melzi R; Maffi P; Secchi A; Sordi V; Piemonti L
Immunology; 2013 Oct; 140(2):179-90. PubMed ID: 23710834
[TBL] [Abstract][Full Text] [Related]
35. Interleukin-12 inhibits the hepatocellular carcinoma growth by inducing macrophage polarization to the M1-like phenotype through downregulation of Stat-3.
Wang Q; Cheng F; Ma TT; Xiong HY; Li ZW; Xie CL; Liu CY; Tu ZG
Mol Cell Biochem; 2016 Apr; 415(1-2):157-68. PubMed ID: 27003285
[TBL] [Abstract][Full Text] [Related]
36. [Interaction between tumor-associated macrophages (TAMs) and HUT-78 lymphoma cells].
Wei C; Wang HT; Jiang ZC; Zhang W; Cao XX; Li TJ; Wang X; Zhou DB
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2014 Aug; 22(4):988-94. PubMed ID: 25130815
[TBL] [Abstract][Full Text] [Related]
37. mTOR signaling pathway regulates the IL-12/IL-10 axis in Leishmania donovani infection.
Cheekatla SS; Aggarwal A; Naik S
Med Microbiol Immunol; 2012 Feb; 201(1):37-46. PubMed ID: 21567173
[TBL] [Abstract][Full Text] [Related]
38. SUSD2 promotes tumor-associated macrophage recruitment by increasing levels of MCP-1 in breast cancer.
Hultgren EM; Patrick ME; Evans RL; Stoos CT; Egland KA
PLoS One; 2017; 12(5):e0177089. PubMed ID: 28475599
[TBL] [Abstract][Full Text] [Related]
39. Tumor associated macrophages provide the survival resistance of tumor cells to hypoxic microenvironmental condition through IL-6 receptor-mediated signals.
Jeong SK; Kim JS; Lee CG; Park YS; Kim SD; Yoon SO; Han DH; Lee KY; Jeong MH; Jo WS
Immunobiology; 2017 Jan; 222(1):55-65. PubMed ID: 26705936
[TBL] [Abstract][Full Text] [Related]
40. Nodal promotes the generation of M2-like macrophages and downregulates the expression of IL-12.
Wang XF; Wang HS; Zhang F; Guo Q; Wang H; Wang KF; Zhang G; Bu XZ; Cai SH; Du J
Eur J Immunol; 2014 Jan; 44(1):173-83. PubMed ID: 24114072
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
